White Paper

Pandemics, Vaccines and Corporate Earnings

October 15, 2020

Reduced growth rates and significant investments in costly risk mitigation have damaged corporate earnings. Harrison Hong, Jeffrey D. Kubik, Neng Wang, Xiao Xu and Jinqiang Yang probe the impact of the pandemic and discuss whether the arrival of a vaccine will cause earnings to revert to normal?